Cancer Incidence and Mortality for All Sites of Cancer, Richmond County (Staten Island), 2008-2012

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males Females Males Females
Average Annual Cases Rate per 100,000 Males 95% CI (+/-) Average Annual Cases Rate per 100,000 Females 95% CI (+/-) Average Annual Deaths Rate per 100,000 Males 95% CI (+/-) Average Annual Deaths Rate per 100,000 Females 95% CI (+/-)
All Invasive Malignant Tumors 1338.0 587.8 14.5 1370.4 486.1 11.7 396.0 188.1 8.6 409.4 141.2 6.2
Oral cavity and pharynx
All Oral cavity and pharynx 33.0 13.6 2.1 15.4 5.4 1.2 7.2 3.0 1.0 3.2 1.2 0.6
Lip 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Tongue 10.8 4.4 1.2 4.0 1.5 0.6 2.2 0.9 0.6 0.4 0.1 0.2
Salivary gland 1.6 0.8 0.6 2.8 0.9 0.5 0.4 0.2 0.3 0.6 0.2 0.2
Floor of mouth 2.2 0.9 0.5 0.6 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.0
Gum & other mouth 4.8 2.2 0.9 3.6 1.3 0.6 0.8 0.3 0.3 0.6 0.2 0.2
Nasopharynx 3.2 1.3 0.6 1.6 0.6 0.4 1.2 0.5 0.4 0.4 0.2 0.2
Tonsil 5.8 2.2 0.8 1.8 0.5 0.4 0.8 0.3 0.3 0.2 0.1 0.1
Oropharynx 1.6 0.7 0.5 0.2 0.1 0.1 0.6 0.3 0.3 0.4 0.1 0.2
Hypopharynx 2.2 0.9 0.5 0.4 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.0
Other buccal cavity and pharynx 0.6 0.2 0.2 0.4 0.1 0.2 0.8 0.4 0.4 0.6 0.2 0.3
Digestive system
All Digestive system 253.8 112.9 6.4 217.6 76.0 4.6 127.6 59.0 4.7 105.6 36.1 3.1
Esophagus 15.2 6.2 1.4 5.2 1.8 0.7 12.4 5.3 1.4 5.0 1.8 0.7
Stomach 25.6 11.7 2.1 16.6 6.0 1.3 11.4 5.6 1.5 8.0 2.7 0.8
Small intestine 7.0 2.9 1.0 4.6 1.7 0.7 0.4 0.2 0.3 0.4 0.1 0.2
Colorectal 116.4 53.9 4.5 121.0 42.3 3.4 42.2 20.7 2.9 43.4 14.8 2.0
Colon excluding rectum 81.2 38.1 3.8 89.4 31.3 3.0 36.4 18.2 2.7 36.8 12.6 1.8
Cecum 11.4 5.5 1.5 22.8 8.0 1.5            
Appendix 1.6 0.7 0.5 4.2 1.6 0.7            
Ascending colon 13.4 6.3 1.5 19.8 7.0 1.4            
Hepatic flexure 3.4 1.7 0.8 3.8 1.3 0.6            
Transverse colon 9.2 4.3 1.3 5.6 2.0 0.7            
Splenic flexure 2.8 1.3 0.7 0.8 0.3 0.3            
Descending colon 7.0 3.2 1.1 3.8 1.3 0.6            
Sigmoid colon 27.8 12.9 2.2 22.2 7.7 1.5            
Large intestine, NOS 4.6 2.2 0.9 6.4 2.1 0.7            
Rectum & rectosigmoid 35.2 15.9 2.4 31.6 11.0 1.7 5.8 2.5 1.0 6.6 2.2 0.8
Rectosigmoid junction 11.6 5.6 1.5 12.0 4.2 1.1            
Rectum 23.6 10.3 1.9 19.6 6.8 1.4            
Anus, anal canal & anorectum 3.6 1.5 0.7 3.8 1.3 0.6 1.0 0.4 0.4 0.8 0.3 0.3
Liver and intrahepatic bile duct 39.6 15.9 2.3 15.4 5.3 1.2 24.8 10.7 2.0 13.0 4.4 1.1
Liver 36.2 14.5 2.2 12.2 4.2 1.1 21.0 9.1 1.8 9.2 3.1 0.9
Intrahepatic bile duct 3.4 1.4 0.7 3.2 1.1 0.5 3.8 1.6 0.7 3.8 1.4 0.6
Gallbladder 2.0 0.9 0.6 4.0 1.4 0.6 2.0 1.0 0.7 2.0 0.7 0.5
Other biliary 4.0 1.7 0.8 3.6 1.3 0.6 0.8 0.3 0.3 0.8 0.3 0.3
Pancreas 37.0 16.5 2.5 37.2 12.8 1.9 32.4 14.5 2.3 30.4 10.4 1.7
Retroperitoneum 1.0 0.5 0.4 1.2 0.5 0.4 0.0 0.0 0.0 0.2 0.1 0.1
Peritoneum, omentum & mesentery 0.8 0.4 0.4 3.2 1.1 0.5 0.2 0.1 0.2 0.8 0.3 0.3
Other digestive organs 1.6 0.8 0.6 1.8 0.6 0.4 0.0 0.0 0.0 0.8 0.3 0.3
Respiratory system
All Respiratory system 194.6 88.1 5.7 169.0 59.6 4.1 125.4 58.6 4.7 107.4 37.2 3.2
Nasal cavity, middle ear & sinuses 2.2 1.0 0.6 1.2 0.4 0.3 0.2 0.1 0.1 0.2 0.1 0.1
Larynx 18.6 7.8 1.6 5.4 1.9 0.7 6.4 2.8 1.0 1.2 0.4 0.3
Lung and bronchus 173.2 79.0 5.4 161.6 57.0 4.0 118.2 55.3 4.6 106.0 36.7 3.2
Pleura 0.0 0.0 0.0 0.4 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.0
Trachea, mediastinum, other respiratory 0.6 0.3 0.3 0.4 0.2 0.2 0.4 0.2 0.3 0.0 0.0 0.0
Soft tissue, bone, and skin
Bones & joints 3.4 1.5 0.7 1.4 0.6 0.5 1.0 0.5 0.4 0.2 0.1 0.1
Soft tissue (including heart) 9.8 4.4 1.3 5.8 2.1 0.8 2.8 1.2 0.7 3.2 1.1 0.6
Skin~ 46.8 20.3 2.7 43.2 15.8 2.1 7.2 3.2 1.1 2.8 1.0 0.5
Melanoma of the skin 42.8 18.6 2.6 39.0 14.3 2.0 5.4 2.4 0.9 2.4 0.9 0.5
Breast
Breast 3.2 1.4 0.7 373.6 131.1 6.0 0.6 0.3 0.3 66.6 22.9 2.5
Female genital system
All Female genital system       168.8 58.3 4.0       49.0 16.7 2.1
Cervix uteri       19.8 7.4 1.5       5.6 1.9 0.7
Corpus uterus and NOS       101.0 34.2 3.0       14.8 5.2 1.2
Ovary       35.8 12.5 1.9       25.6 8.7 1.5
Vagina       1.8 0.6 0.4       1.0 0.3 0.3
Vulva       7.4 2.5 0.8       1.2 0.4 0.3
Other female genital organs       3.0 1.0 0.5       0.8 0.2 0.2
Male genital system
All Male genital system 366.0 153.6 7.3       32.2 17.9 2.8      
Prostate 347.8 145.1 7.0       30.8 17.2 2.8      
Testis 14.8 6.8 1.6       0.6 0.3 0.3      
Penis 2.6 1.4 0.8       0.8 0.4 0.4      
Other male genital organs 0.8 0.3 0.3       0.0 0.0 0.0      
Urinary system
All Urinary system 164.0 73.2 5.2 66.4 23.1 2.5 24.8 11.8 2.2 13.0 4.4 1.1
Urinary bladder (including in situ) 97.0 44.9 4.1 30.6 10.5 1.7 15.0 7.5 1.7 6.0 2.0 0.7
Kidney and renal pelvis 61.0 25.2 2.9 33.8 11.8 1.8 9.6 4.3 1.2 6.6 2.3 0.8
Ureter 2.0 1.1 0.7 1.0 0.4 0.4 0.2 0.1 0.2 0.2 0.1 0.2
Other urinary organs 4.0 2.0 0.9 1.0 0.3 0.3 0.0 0.0 0.0 0.2 0.1 0.1
Eye & orbit
Eye & orbit 2.8 1.1 0.6 1.8 0.6 0.4 0.2 0.1 0.1 0.2 0.1 0.2
Brain and central nervous system
All Brain / other nervous system (all behaviors) 30.2 12.9 2.1 52.0 18.9 2.4 8.6 3.8 1.2 10.2 3.7 1.0
Malignant brain / other nervous system 16.2 7.1 1.6 15.4 6.0 1.4 7.6 3.4 1.1 8.4 3.1 0.9
Malignant brain 15.2 6.6 1.5 13.2 5.0 1.2            
Malignant other nervous system 1.0 0.4 0.4 2.2 0.9 0.6            
Benign brain / other nervous system* 14.0 5.9 1.4 36.6 12.9 1.9 1.0 0.4 0.3 1.8 0.6 0.4
Benign brain 1.2 0.6 0.5 2.0 0.9 0.6            
Benign other nervous system 12.8 5.3 1.3 34.6 12.1 1.8            
Endocrine system
All Endocrine system 40.2 16.5 2.3 121.4 46.5 3.8 1.2 0.5 0.4 1.8 0.7 0.4
Thyroid 37.6 15.3 2.2 118.8 45.4 3.7 0.4 0.1 0.2 0.8 0.3 0.3
Other endocrine (including thymus) 2.6 1.2 0.7 2.6 1.1 0.6 0.8 0.3 0.3 1.0 0.4 0.3
Lymphomas
All Lymphomas 68.0 30.7 3.4 65.8 24.2 2.7 17.2 8.1 1.8 12.0 4.4 1.1
Hodgkin lymphoma 10.0 4.3 1.2 8.6 3.6 1.1 1.2 0.5 0.4 0.0 0.0 0.0
Non-Hodgkin lymphomas 58.0 26.4 3.1 57.2 20.5 2.4 16.0 7.6 1.7 12.0 4.4 1.1
Myeloma
All Myeloma 23.6 10.7 2.0 18.0 6.3 1.3 5.2 2.4 1.0 4.4 1.6 0.7
Leukemias
All Leukemias 48.4 22.2 2.9 35.4 12.6 1.9 15.6 7.9 1.8 13.0 4.6 1.1
Lymphocytic leukemias 27.8 12.5 2.1 18.4 6.6 1.4 2.8 1.4 0.8 4.2 1.5 0.6
Acute lymphocytic leukemia 4.8 2.2 0.9 3.0 1.3 0.7 0.8 0.3 0.3 0.4 0.2 0.2
Chronic lymphocytic leukemia 19.8 8.8 1.8 15.2 5.2 1.2 1.8 1.0 0.7 3.8 1.3 0.6
Other lymphocytic leukemias 3.2 1.4 0.7 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.0 0.0
Myeloid and monocytic leukemias 18.6 8.8 1.8 14.8 5.3 1.2 9.2 4.6 1.4 5.8 2.1 0.8
Acute myeloid leukemia 11.4 5.4 1.4 11.0 4.0 1.1 7.6 3.8 1.2 4.6 1.6 0.7
Acute monocytic leukemia 0.4 0.2 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0
Chronic myeloid leukemia 5.6 2.5 0.9 3.4 1.1 0.5 0.6 0.3 0.4 0.2 0.1 0.1
Other myeloid/monocytic leukemias 1.2 0.7 0.6 0.2 0.1 0.2 1.0 0.5 0.4 1.0 0.4 0.3
Other leukemias 2.0 1.0 0.6 2.2 0.7 0.5 3.6 1.8 0.9 3.0 1.1 0.6
Other acute leukemias 0.6 0.3 0.4 1.2 0.4 0.3 1.0 0.5 0.4 1.2 0.4 0.4
Aleukemic, subacute, leukemia NOS 1.4 0.7 0.5 1.0 0.3 0.3 2.6 1.4 0.8 1.8 0.7 0.4
Mesothelioma
Mesothelioma 4.2 2.1 0.9 1.2 0.4 0.3            
Kaposi sarcoma
Kaposi sarcoma 4.2 2.1 0.9 0.4 0.1 0.2            
Myelodysplastic syndromes
Myelodysplastic syndromes 13.6 6.8 1.7 9.6 3.2 0.9            
Chronic myeloproliferative disorders^
Chronic myeloproliferative disorders^ 18.0 7.9 1.7 17.2 6.4 1.4            
Ill defined and unspecified sites
Ill defined and unspecified sites 24.2 11.4 2.1 23.0 7.8 1.4 20.2 10.2 2.0 18.6 6.2 1.3

Key

Symbol Meaning
~ Incidence of skin cancer excludes basal and squamous cell cancers.
* Brain and other nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^ Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

  • Incidence data are provisional, November 2014.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.